Vaxneuvance pneumococcal 15-valent conjugate vaccine Images
Generic Name: pneumococcal 15-valent conjugate vaccine
This medication has been identified as Vaxneuvance pneumococcal 15-valent conjugate vaccine. It is supplied by Merck.
Vaxneuvance is used in the treatment of Pneumococcal Disease Prophylaxis and belongs to the drug class bacterial vaccines. Vaxneuvance pneumococcal 15-valent conjugate vaccine is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Vaxneuvance
- Generic Name
- pneumococcal 15-valent conjugate vaccine
- Strength
- pneumococcal 15-valent conjugate vaccine
- Availability
- Prescription only
- Drug Class
- Bacterial vaccines
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Merck
- National Drug Code (NDC)
- 00006-4329
More about Vaxneuvance (pneumococcal 15-valent conjugate vaccine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: bacterial vaccines
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
